Notogen is developing a novel biologic regenerative therapy to treat degenerative disc disease (i.e. chronic back and neck pain as a result of degenerating spinal discs). The product, which is pre-clinical and currently undergoing cGMP manufacturing, is an injectable solution that is fast to administer, cost-effective, and minimally invasive to patients. The unique approach helps the body arrest degeneration and repair and regenerate spinal disc tissues, while reducing pain and inflammation. Based on more than 20 years of clinical and laboratory research, this novel therapeutic has the potential to improve the lives of millions of people worldwide suffering from chronic back and neck pain. Notogen is headquartered in Toronto, Canada.
| Website | http://www.notogen.com |
| Employees | 3 (3 on RocketReach) |
| Founded | 2016 |
| Address | 661 University Avenue, Suite 13-1387, Toronto, Ontario M5G 0B7, CA |
| Phone | +1 647-243-5278 |
| Technologies |
JavaScript
,
Google Analytics
,
reCAPTCHA
+14 more
(view full list)
|
| Industry | Biotechnology, Therapeutic Devices, Science and Engineering, Other Healthcare Technology Systems, Life Science, Therapeutics, Health Care |
| Keywords | Degenerative Disc Disease, Regenerative Medicine, Regenerative Therapies, Tissue Regeneration, Cell Therapy, Back Pain Relief, Neck Pain Relief, Spinal Health, Biopharmaceutical, Preclinical Trials, Cgmp Manufacturing, Orthopedic Treatments, Pain Management, Drug Development |
| Competitors | Illumina, Ancestry, Myriad Genetics, Foundation Medicine, GeneDx, Invitae, Fulgent Genetics, 23andMe, Gene by Gene, Color +31 more (view full list) |
Looking for a particular Notogen Inc. employee's phone or email?
Gary Margolis is the CEO of Notogen Inc..
3 people are employed at Notogen Inc..
Notogen Inc. is based in Toronto, Ontario.